Form 8-K - Current report:
SEC Accession No. 0001437749-25-007120
Filing Date
2025-03-12
Accepted
2025-03-12 08:00:25
Documents
15
Period of Report
2025-03-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K clnn20250311_8k.htm   iXBRL 8-K 28538
2 EXHIBIT 99.1 ex_788726.htm EX-99.1 26311
  Complete submission text file 0001437749-25-007120.txt   215708

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA clnn-20250312.xsd EX-101.SCH 3944
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clnn-20250312_def.xml EX-101.DEF 13905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clnn-20250312_lab.xml EX-101.LAB 18375
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clnn-20250312_pre.xml EX-101.PRE 13937
17 EXTRACTED XBRL INSTANCE DOCUMENT clnn20250311_8k_htm.xml XML 5061
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39834 | Film No.: 25730023
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)